Video Experimental Relacionado
Updated: Aug 11, 2026
11:19
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
La pediatría es la medicina de los niños
1Johns Hopkins University School of Medicine, Baltimore, Md, USA.
JAMA
|June 7, 1995
Resumen
El tabaquismo materno durante el embarazo está relacionado con menores puntuaciones de CI del niño. El uso rutinario de esteroides nebulizados puede disminuir las hospitalizaciones por crup.
Área de la Ciencia:
- La pediatría es la medicina de los niños.
- Obstetrías y Obstetricia.
- Psicología del desarrollo Psicología del desarrollo.
Sus antecedentes:
- El tabaquismo materno durante el embarazo es un factor de riesgo conocido para resultados adversos en el niño.
- El crup es una enfermedad respiratoria común en los niños que puede requerir hospitalización.
Objetivo del estudio:
- Investigar la asociación entre el tabaquismo materno durante el embarazo y el coeficiente intelectual de la descendencia.
- Evaluar la efectividad del uso rutinario de esteroides nebulizados en el manejo del crup y la reducción de los ingresos hospitalarios.
Principales métodos:
- Análisis retrospectivo de los datos de nacimiento y CI.
- Ensayo clínico que compara los esteroides nebulizados con el placebo para el manejo del crup.
Principales resultados:
- Los hijos de madres que fumaron durante el embarazo exhibieron puntuaciones de CI significativamente más bajas en comparación con las no fumadoras.
- La administración rutinaria de esteroides nebulizados para el crup demostró una tasa reducida de hospitalización.
Conclusiones:
- La exposición prenatal al humo tiene un impacto negativo en el desarrollo cognitivo de los niños.
- Los esteroides nebulizados representan una opción terapéutica viable para reducir las hospitalizaciones relacionadas con el crup en pacientes pediátricos.
Videos de Conceptos Relacionados
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...